BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10649208)

  • 1. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients.
    Hawkins JA; Breinholt JP; Lambert LM; Fuller TC; Profaizer T; McGough EC; Shaddy RE
    J Thorac Cardiovasc Surg; 2000 Feb; 119(2):324-30. PubMed ID: 10649208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts.
    Hawkins JA; Hillman ND; Lambert LM; Jones J; Di Russo GB; Profaizer T; Fuller TC; Minich LL; Williams RV; Shaddy RE
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):247-52; discussion 252-3. PubMed ID: 12878962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized trial of azathioprine in cryopreserved valved allografts in children.
    Shaddy RE; Lambert LM; Fuller TC; Profaizer T; Thompson DD; Baker SI; Osborne KA; Hawkins JA
    Ann Thorac Surg; 2001 Jan; 71(1):43-7; discussion 47-8. PubMed ID: 11216808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation.
    Meyer SR; Campbell PM; Rutledge JM; Halpin AM; Hawkins LE; Lakey JR; Rebeyka IM; Ross DB
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):554-60. PubMed ID: 15784350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery.
    Shaddy RE; Hunter DD; Osborn KA; Lambert LM; Minich LL; Hawkins JA; McGough EC; Fuller TC
    Circulation; 1996 Sep; 94(5):1063-7. PubMed ID: 8790047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panel-reactive antibodies late after allograft implantation in children.
    Hooper DK; Hawkins JA; Fuller TC; Profaizer T; Shaddy RE
    Ann Thorac Surg; 2005 Feb; 79(2):641-4; discussion 645. PubMed ID: 15680851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation.
    Shaddy RE; Fuller TC; Anderson JB; Lambert LM; Brinkman MK; Profaizer T; Hawkins JA
    Ann Thorac Surg; 2004 May; 77(5):1734-9; discussion 1739. PubMed ID: 15111175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective analysis of the immunogenicity of cryopreserved nonvalved allografts used in pediatric heart surgery.
    Breinholt JP; Hawkins JA; Lambert LM; Fuller TC; Profaizer T; Shaddy RE
    Circulation; 2000 Nov; 102(19 Suppl 3):III179-82. PubMed ID: 11082383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of human leukocyte antigen (HLA) antibodies after one year in children receiving cryopreserved valved allografts.
    Shaddy RE; Thompson DD; Osborne KA; Hawkins JA; Fuller TC
    Am J Cardiol; 1997 Aug; 80(3):358-9. PubMed ID: 9264439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midterm results with cryopreserved allograft valved conduits from the right ventricle to the pulmonary arteries.
    Hawkins JA; Bailey WW; Dillon T; Schwartz DC
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):910-6. PubMed ID: 1405689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-year monitoring of the donor-specific immune response to cryopreserved aortic allograft valves: implications with valve dysfunction.
    Pompilio G; Polvani G; Piccolo G; Guarino A; Nocco A; Innocente A; Porqueddu M; Dainese L; Veglia F; Sala A; Biglioli P
    Ann Thorac Surg; 2004 Aug; 78(2):557-63. PubMed ID: 15276519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of humoral immune response to donor HLA after implantation of cellularized versus decellularized human heart valve allografts.
    Kneib C; von Glehn CQ; Costa FD; Costa MT; Susin MF
    Tissue Antigens; 2012 Aug; 80(2):165-74. PubMed ID: 22631597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies.
    Hoekstra FM; Witvliet M; Knoop CY; Wassenaar C; Bogers AJ; Weimar W; Claas FH
    Ann Thorac Surg; 1998 Dec; 66(6):2022-6. PubMed ID: 9930487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HLA antibodies after cryopreserved allograft valve implantation does not predict valve dysfunction at three-year follow up.
    Yap CH; Skillington PD; Matalanis G; Davis BB; Tait BD; Hudson F; Ireland L; Nixon I; Yiil M
    J Heart Valve Dis; 2006 Jul; 15(4):540-4. PubMed ID: 16901051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults.
    Vogt PR; Stallmach T; Niederhäuser U; Schneider J; Zünd G; Lachat M; Künzli A; Turina MI
    Eur J Cardiothorac Surg; 1999 May; 15(5):639-44; discussion 644-5. PubMed ID: 10386410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year reduction of panel reactive human leukocyte antigen antibodies in children receiving mycophenolate mofetil after valved allograft placement.
    Anderson JB; Fuller TC; Hawkins JA; Brinkman MK; Profaizer T; Shaddy RE
    Transplantation; 2005 Aug; 80(3):414-6. PubMed ID: 16082339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricle-to-pulmonary artery conduit longevity: is it related to allograft size?
    Askovich B; Hawkins JA; Sower CT; Minich LL; Tani LY; Stoddard G; Puchalski MD
    Ann Thorac Surg; 2007 Sep; 84(3):907-11; discussion 911-2. PubMed ID: 17720398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen mismatch and other factors affecting cryopreserved allograft valve function.
    Yap CH; Skillington PD; Matalanis G; Davis BB; Tait BD; Hudson F; Ireland L; Nixon I; Yii M
    Heart Surg Forum; 2008; 11(1):E42-5. PubMed ID: 18270140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Banking of cryopreserved heart valves in Europe: assessment of a 10-year operation in the European Homograft Bank (EHB).
    Goffin YA; Van Hoeck B; Jashari R; Soots G; Kalmar P
    J Heart Valve Dis; 2000 Mar; 9(2):207-14. PubMed ID: 10772038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.